Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
24 participants
INTERVENTIONAL
2006-05-31
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Oglemilast for the Treatment of Asthma
NCT00322686
A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma
NCT00859404
Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation
NCT01232322
Preventing Asthma in High Risk Kids
NCT02570984
Study of the Mechanisms of Asthma
NCT00595153
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oglemilast
Oglemilast
Oglemilast, 15mg once per day, oral administration
Placebo
Placebo
Dose-marched placebo, once per day, oral administration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oglemilast
Oglemilast, 15mg once per day, oral administration
Placebo
Dose-marched placebo, once per day, oral administration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Forest Laboratories
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Forest Investigative Site
Los Angeles, California, United States
Forest Investigative Site
North Dartmouth, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GRC-MD-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.